Annual Drug Patent Expirations for GENOSYL Genosyl is a drug marketed by Vero Biotech and is included in one NDA. There are twenty patents protecting this drug. This drug has…
The post New patent expiration for Vero Biotech drug GENOSYL appeared first …
New patent expiration for Vero Biotech drug GENOSYL Read Post »
Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Intercept Pharms drug OCALIVA appeared first …
New patent expiration for Intercept Pharms drug OCALIVA Read Post »
Annual Drug Patent Expirations for METROGEL Metrogel is a drug marketed by Galderma Labs Lp and Bausch and is included in three NDAs. It is available from two suppliers. There…
The post New patent expiration for Galderma Labs drug METROGEL appeared fir…
New patent expiration for Galderma Labs drug METROGEL Read Post »
Annual Drug Patent Expirations for PREVACID+IV Prevacid Iv is a drug marketed by Takeda Pharms Na and is included in one NDA. There is one patent protecting this drug. The…
The post New patent expiration for Takeda Pharms drug PREVACID IV appeared firs…
New patent expiration for Takeda Pharms drug PREVACID IV Read Post »
KYNMOBI (apomorphine hydrochloride) Sunovion pharms inc Patent: 9,855,221 Expiration: Feb 14, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expir…
Drug Patent Expirations for the Week of February 13, 2022 Read Post »
Annual Drug Patent Expirations for LEVOXYL Levoxyl is a drug marketed by King Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for King Pharms drug LEVOXYL appeared first on D…
New patent expiration for King Pharms drug LEVOXYL Read Post »
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Indivior Inc drug SUBOXONE appeared firs…
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent expiration for Sunovion Pharms drug KYNMOBI appeared fir…
New patent expiration for Sunovion Pharms drug KYNMOBI Read Post »
Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are ten patents protecting…
The post New patent expiration for Astrazeneca drug SYMBICORT a…
New patent expiration for Astrazeneca drug SYMBICORT Read Post »
SYMBICORT (budesonide; formoterol fumarate dihydrate) Astrazeneca Patent: 7,967,011 Expiration: Feb 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Pa…
Drug Patent Expirations for the Week of February 6, 2022 Read Post »